DMARDs for RA Improve Vascular Inflammation and CV Risk
Receipt of a tumor necrosis factor inhibitor or triple therapy for rheumatoid arthritis yielded an equally beneficial effect for reducing vascular inflammation and cardiovascular risk.
Source: medscape.com